A: Our services are meant to be an extension or enhancement from what you currently have in place for filing claims. You can keep your current services consistent, but utilize Recovery Solutions Capital to expand the opportunities for recoveries.
A: Recovery Solutions Capital is not owned or a subsidiary of any other company.
A: Yes, we have a group of investors with a set of funds for immediate purchases with a further agreement for significant future investments if/when needed.
A: Yes. The bid generation process is quite easy for any firm.
A: Yes. There is greater value for more recent trading, but overall there is potential value in funds for up to ten years after trading stopped.
A: To provide the most accurate bid, we’d need to know details on historical recoveries, claims filed but not yet distributed, and potential eligibility on cases yet to be filed. However, our modeling allows for bids to be created on far less information, but the more information available the better.
A: Once a contract is signed the money can be distributed within two to three business days.
A: No. Today, Opt-In claims are only possible in certain jurisdictions, and we will bid on any Opt-In claims.
A: Our price is dependent upon a clients’ needs. There are different fees if you only want general assistance on looking at different vendors vs. assistance on a global review of best practices. We engage with our clients to understand their specific needs to create an attractive pricing model.
In January 2016, Merck & Co said it would pay $830 million to settle a …
In June 2016, BP Plc agreed to pay $175 million to shareholders who brought a …
In August 2016, Pfizer Inc. reached a $486 million settlement regarding a litigation case accusing …